Colgate Palmolive
Colgate-Palmolive (India) Ltd
- Market Cap
- ₹47,869 Cr
- P/E
- 35.15
Key Fundamentals
MidcapPersonal ProductsFMCGPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 108.00%
- Debt to Equity
- 0.03
- EPS (TTM)
- ₹50.07
- Book Value
- ₹59.45
- Market Cap
- ₹47,869 Cr
- P/E (TTM)
- 35.15
- P/B
- 29.60
- ROE
- 82.70%
- Dividend Yield
- 1.35%
- EBITDA
- ₹1,959 Cr
- 52W High
- ₹2,301.60
- 52W Low
- ₹1,563.90
- Day Range
- ₹1,756.50 – ₹1,782.30
- Volume
- 3,51,315
Peer Comparison
Fast Moving Consumer Goods › Personal Products › Personal Care
| 919.50 | 47.57 | 94,093 | 7.46 | 1.67% | 16.10% | 18.80% | 16,537 | 1,978 | |
| 393.10 | 34.42 | 69,734 | 6.07 | 0.92% | 17.00% | 20.30% | 13,924 | 2,001 | |
| 365.65 | 290.20 | 49,168 | 87.48 | 1.38% | 27.60% | 33.90% | 602 | 169 | |
| 1,760.00 | 35.15 | 47,869 | 29.60 | 1.42% | 82.70% | 108.00% | 6,391 | 1,362 | |
| 7,090.50 | 33.80 | 23,105 | 21.51 | 3.31% | 66.50% | 90.70% | 3,211 | 683 | |
| 7,020.00 | 29.34 | 22,787 | 25.78 | 3.73% | 115.00% | 157.00% | 4,240 | 776 | |
| 422.20 | 24.76 | 18,429 | 6.30 | 1.21% | 26.20% | 28.10% | 4,204 | 747 | |
| Median 7 companies | 919.50 | 34.42 | 47,869 | 21.51 | 1.42% | 27.60% | 33.90% | 4,240 | 776 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 85
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 36
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 50
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 91
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 33
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 46
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 79.4%
- Company has been maintaining a healthy dividend payout of 112%
Weaknesses
2- Stock is trading at 29.6 times its book value
- The company has delivered a poor sales growth of 4.51% over past five years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 7 | 4 | 8 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Strong Bullish | 4 | 0 | 6 |
Oscillators
Bearish
Overall
Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 55.98
- Neutral
- MACD (12,26,9)
- 1.94
- Bullish
- SMA (50)
- 1,748.61
- Bullish
- SMA (200)
- 1,969.92
- Bearish
As of
Analyst Rating
7 of 26 analysts rate Buy, 9 Hold, 10 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +4.55% |
|---|---|
| 5Y | +4.51% |
| 3Y | +4.91% |
| 1Y | −0.08% |
| TTM | +8.69% |
Net profit
| 10Y | +8.59% |
|---|---|
| 5Y | +5.06% |
| 3Y | +8.17% |
| 1Y | −7.79% |
| TTM | +2.64% |
Operating cash flow
| 10Y | +10.12% |
|---|---|
| 5Y | +18.16% |
| 3Y | +15.37% |
| 1Y | +29.56% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +6.69 pp |
|---|---|
| 5Y | −0.20 pp |
| 3Y | +1.39 pp |
| 1Y | −1.43 pp |
| TTM | −1.95 pp |
Revenue by year
| Mar 2017 | ₹3,982 Cr |
|---|---|
| Mar 2018 | ₹4,188 Cr |
| Mar 2019 | ₹4,462 Cr |
| Mar 2020 | ₹4,525 Cr |
| Mar 2021 | ₹4,841 Cr |
| Mar 2022 | ₹5,100 Cr |
| Mar 2023 | ₹5,226 Cr |
| Mar 2024 | ₹5,680 Cr |
| Mar 2025 | ₹6,040 Cr |
| Mar 2026 | ₹6,035 Cr |
Net profit by year
| Mar 2017 | ₹577 Cr |
|---|---|
| Mar 2018 | ₹673 Cr |
| Mar 2019 | ₹776 Cr |
| Mar 2020 | ₹816 Cr |
| Mar 2021 | ₹1,035 Cr |
| Mar 2022 | ₹1,078 Cr |
| Mar 2023 | ₹1,047 Cr |
| Mar 2024 | ₹1,324 Cr |
| Mar 2025 | ₹1,437 Cr |
| Mar 2026 | ₹1,325 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Colgate-Palmolive (India) Ltd trades at ₹1,719.7 as of 2026-11-17 with a market cap of ₹46,773 crore, a trailing P/E of 34.35x, and an exceptionally high ROE of 83.66%. The company is virtually debt-free with a debt-to-equity ratio of 0.03 but has seen its stock decline roughly 25% from its 52-week high of ₹2,301.6, reflecting investor concerns around tepid profit growth and rich valuations.
- Near-zero leverage with a debt-to-equity ratio of just 0.03, providing significant financial flexibility and resilience through economic cycles.
- Exceptional return on equity of 83.66% and ROCE of 107.36% as of 2026-11-17, indicating highly efficient capital deployment relative to almost any listed FMCG peer.
- Consistent ROE track record averaging 79% over 3 years and 75% over 5 years, demonstrating durable competitive advantages in oral care.
- Healthy dividend payout of 112% with a current dividend yield of 1.41%, making it attractive for income-oriented portfolios in the FMCG space.
- TTM sales growth has accelerated to 9%, meaningfully above the 5% compounded sales growth seen over both 3-year and 5-year periods, suggesting improving top-line momentum.
- Compounded sales growth of 5% over 10 years reflects steady, defensive revenue characteristics typical of a dominant oral care franchise in India.
- Stock is trading 25.3% below its 52-week high of ₹2,301.6, offering a more compressed entry valuation compared to recent peaks.
- Price-to-book ratio of 28.91x is extremely high, reflecting a stock priced for perfection with minimal room for execution missteps.
- Compounded profit growth of just 5% over 5 years and 4% on a TTM basis lags nominal GDP growth, raising questions about earnings power expansion.
- Stock CAGR of -21% over the past 1 year and -7% over 3 years indicates sustained price underperformance, suggesting the market has been repricing the stock lower.
- 5-year compounded sales growth of 5% is modest for an Indian FMCG company operating in a large underpenetrated market, pointing to potential category maturity in core oral care.
- 10-year stock CAGR of only 6% has significantly underperformed broader Indian equity indices over the same period, questioning long-term wealth creation potential.
- Dividend payout exceeding 112% of earnings means the company is returning more than it earns, which is unsustainable long-term unless earnings growth reaccelerates.
- TTM EPS of ₹50.07 growing at just 4% offers limited near-term earnings catalyst to support the current 34.35x P/E multiple.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Colgate-Palmolive (India) is returning cash to shareholders with a healthy ₹24 per share interim dividend and maintaining active investor engagement through multiple scheduled meets. A leadership transition is underway with a postal ballot for a new MD & CEO. No material headwinds emerged in recent news flow, though the upcoming leadership change warrants monitoring for strategic continuity.
- ₹24 interim dividend declared Oct 23
Colgate-Palmolive (India) declared a first interim dividend of ₹24 per share for FY26, with a record date of November 2, 2026.
- New MD & CEO appointment vote Oct 30
Postal ballot initiated to appoint Manish Anandani as MD & CEO, with voting open from October 31 to November 29, 2026.
- Multiple investor meets scheduled Nov 10
Colgate-Palmolive (India) scheduled analyst/investor meetings on November 16, 18, and 26, 2026. No unpublished price-sensitive information will be shared.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,471 | 1,396 | 1,490 | 1,497 | 1,619 | 1,462 | 1,463 | 1,434 | 1,520 | 1,486 | 1,595 | 1,603 | 1,706 |
| Expenses | 989 | 927 | 958 | 988 | 1,122 | 1,007 | 964 | 981 | 1,054 | 1,044 | 1,086 | 1,120 | 1,232 |
| Operating Profit | 482 | 468 | 532 | 508 | 497 | 454 | 498 | 453 | 465 | 442 | 510 | 483 | 473 |
| OPM % | 33% | 34% | 36% | 34% | 31% | 31% | 34% | 32% | 31% | 30% | 32% | 30% | 28% |
| Other Income | 21 | 18 | 23 | 23 | 76 | 20 | 19 | 18 | 15 | 39.28 | 0 | 19 | 22 |
| Interest | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 44 | 41 | 42 | 42 | 42 | 41 | 38 | 38 | 37 | 36 | 35 | 39 | 34 |
| Exceptional Items | — | — | — | — | — | — | — | — | — | −8.39 | — | — | — |
| PBT | 458 | 443 | 511 | 489 | 530 | 433 | 478 | 432 | 442 | 436 | 474 | 462 | 460 |
| Tax % | 26% | 26% | 26% | 26% | 26% | 25% | 26% | 26% | 26% | 26% | 25% | 26% | 26% |
| Net Profit | 340 | 330 | 380 | 364 | 395 | 323 | 355 | 321 | 328 | 324 | 353 | 343 | 342 |
| EPS (₹) | 12.50 | 12.14 | 13.96 | 13.38 | 14.52 | 11.87 | 13.05 | 11.79 | 12.04 | 11.91 | 12.99 | 12.61 | 12.56 |
| YoY Sales growth | 6 | 8 | 10 | 13 | 10 | 5 | −2 | −4 | −6 | 2 | 9 | 12 | 12 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,982 | 3,868 | 3,982 | 4,188 | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,040 | 6,035 | 6,391 |
| Expenses | 3,159 | 2,929 | 3,038 | 3,074 | 3,226 | 3,323 | 3,331 | 3,534 | 3,679 | 3,779 | 4,082 | 4,165 | 4,482 |
| Operating Profit | 823 | 940 | 944 | 1,114 | 1,236 | 1,202 | 1,510 | 1,566 | 1,547 | 1,901 | 1,958 | 1,870 | 1,908 |
| OPM % | 21% | 24% | 24% | 27% | 28% | 27% | 31% | 31% | 30% | 33% | 32% | 31% | 30% |
| Other Income | 32 | 7 | 41 | 26 | 37.66 | 49 | 30 | 26 | 53.58 | 76.52 | 139 | 89.12 | 72 |
| Interest | 0 | 0 | 0 | 0 | 2 | 10 | 7 | 6 | 5 | 5 | 4 | 4 | 4 |
| Depreciation | 75 | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 163 | 146 | 145 |
| Exceptional Items | — | — | — | — | 30.51 | — | — | — | −11.21 | −19.5 | — | −24.97 | — |
| PBT | 780 | 835 | 851 | 983 | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,930 | 1,784 | 1,832 |
| Tax % | 28% | 30% | 32% | 32% | 32% | 22% | 23% | 23% | 26% | 26% | 26% | 26% | — |
| Net Profit | 559 | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,437 | 1,325 | 1,362 |
| EPS (₹) | 20.55 | 21.37 | 21.23 | 24.76 | 28.52 | 30.02 | 38.07 | 39.65 | 38.50 | 48.67 | 52.83 | 48.73 | 50.07 |
| Div. Payout % | 58% | 47% | 47% | 97% | 81% | 93% | 100% | 101% | 101% | 119% | 97% | 119% | — |
| Sales growth | 11 | −3 | 3 | 5 | 7 | 1 | 7 | 5 | 2 | 9 | 6 | 0 | 9 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 757 | 1,004 | 1,247 | 1,497 | 1,420 | 1,567 | 1,139 | 1,707 | 1,689 | 1,847 | 1,637 | 1,557 | 1,590 |
| Borrowings | 0 | 0 | 0 | 0 | 83 | 102 | 91 | 83 | 69 | 72 | 61 | 47 | 49 |
| Other Liabilities | 932 | 972 | 1,037 | 1,039 | 1,097 | 908 | 1,637 | 1,084 | 1,098 | 1,250 | 1,293 | 1,777 | 1,971 |
| Total Liabilities | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,408 | 3,638 |
| Fixed Assets | 782 | 1,008 | 1,108 | 1,146 | 1,191 | 1,123 | 1,065 | 963 | 862 | 794 | 776 | 718 | 673 |
| CWIP | 141 | 78 | 167 | 159 | 199 | 190 | 145 | 122 | 114 | 110 | 38 | 27 | 52 |
| Investments | 37 | 31 | 31 | 31 | 31 | 19 | 19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 742 | 885 | 1,005 | 1,228 | 1,206 | 1,272 | 1,666 | 1,817 | 1,907 | 2,292 | 2,204 | 2,663 | 2,913 |
| Total Assets | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,408 | 3,638 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 638 | 689 | 688 | 694 | 983 | 930 | 784 | 1,626 | 1,176 | 1,199 | 1,394 | 1,806 |
| Investing | −272 | −237 | −342 | −207 | −96 | −19 | 71 | −108 | −8 | 79 | 56 | 374 |
| Financing | −385 | −391 | −341 | −380 | −815 | −891 | −956 | −1,091 | −1,087 | −1,195 | −1,671 | −1,422 |
| Net Cash Flow | −18 | 61 | 5 | 107 | 73 | 20 | −101 | 427 | 82 | 83 | −221 | 758 |
| Free Cash Flow | 339 | 417 | 367 | 485 | 879 | 869 | 727 | 1,576 | 1,107 | 1,123 | 1,323 | 1,730 |
| CFO/EBITDA | 103 | 100 | 105 | 93 | 113 | 104 | 76 | 127 | 101 | 88 | 100 | 121 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 | 14 | 13 |
| Inventory Days | 63 | 72 | 72 | 56 | 58 | 69 | 79 | 78 | 68 | 63 | 76 | 75 |
| Days Payable | 128 | 136 | 148 | 152 | 144 | 142 | 179 | 169 | 155 | 187 | 185 | 275 |
| Cash Conversion Cycle | −59 | −55 | −63 | −79 | −68 | −63 | −91 | −75 | −76 | −113 | −95 | −188 |
| Working Capital Days | −40 | −43 | −39 | −33 | −36 | −23 | −84 | −25 | −32 | −46 | −37 | −59 |
| ROCE % | 114% | 96% | 74% | 71% | 73% | 65% | 92% | 92% | 79% | 97% | 105% | 108% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Colgate Palmolive insights
70 extracted metrics across FY03–FY27.
Documents
- Concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Q4 FY25 concall · May 2025Transcript PPT
- Concall · Feb 2025PPT
- Concall · Dec 2024Transcript PPT
- 29 Jul 2026
- 22 May 2026
- General announcements 10 Nov 2026
- General announcements 10 Nov 2026
Frequently Asked Questions about Colgate Palmolive
What does Colgate-Palmolive (India) Ltd do?
Where is Colgate-Palmolive (India) Ltd (COLPAL) listed?
Which sector does Colgate-Palmolive (India) Ltd belong to?
What is the market capitalisation of Colgate-Palmolive (India) Ltd?
What is the PE ratio of Colgate-Palmolive (India) Ltd?
What is the 52-week high and low of Colgate-Palmolive (India) Ltd?
Does Colgate-Palmolive (India) Ltd pay dividends?
What is the Return on Equity (ROE) of Colgate-Palmolive (India) Ltd?
Company Information
Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/COLPAL.md for Colgate-Palmolive (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.